BERLIN (dpa-AFX) - German drug distributor Celesio Group (CAKFF.PK) reported Wednesday that its net loss was 222.3 million euros or 1.10 euros per share in the short fiscal year 2015 ended March 31.
In the first quarter of 2014, the company's net profit was 43.1 million euros or 0.22 euros per share.
Net loss from discontinued operations was 255.3 million euros, and net profit from continuing operations was 33 million euros in the short fiscal year.
The results for the Brazilian businesses, Panpharma and Oncoprod, are reported as discontinued operations.
Celesio generated group revenue of 5.27 billion euros in short fiscal year 2015. The previous-year period figure was 4.99 billion euros.
Looking ahead, the company said that with the exception of the decision to place Brazilian business for sale, the outlook for continued operations remains unchanged from previous guidance.
Celesio assumes that revenue from continued operations for fiscal 2016 will be flat compared to the adjusted fiscal 2014 as solid growth in Germany and the United Kingdom will be offset by continued weakness in France and the loss of a large hospital contract in Norway.
The adjusted EBIT for continued operations for fiscal 2016 will be considerably below the level of the adjusted fiscal 2014 due to a non-recurring pension benefit in fiscal 2014 in Norway.
Copyright RTT News/dpa-AFX